Causes of involutional ptosis
October 23, 2021
The development of involutional ptosis may be a multifactorial process, researchers have found.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Ptosis
Oxymetazoline hydrochloride honored by Allure magazine
November 19, 2021
Oxymetazoline hydrochloride has been recognized by the publication as a winner of its Best of Beauty Breakthrough Award.
Anophthalmic ptosis and enucleation effects on upper eyelid function
October 17, 2021
New data finds that preoperative ptosis occurs commonly and more often in patients with reactive blepharospasm or enophthalmos.
Exploring ptosis development after pars plana vitrectomy
October 01, 2021
Researchers consider frequency and factors in etiology of complication
Upper lid elevation with topical oxymetazoline 0.1%: providing a better view
September 22, 2021
Topical oxymetazoline HCL ophthalmic solution 0.1% (RVL-1201, RVL Pharmaceuticals, Inc.) has the potential to treat patients with varying degrees of severity of acquired ptosis compared with vehicle.
Orbital lymphoma: masquerading as involutional ptosis
September 15, 2021
Unilateral ptosis can be the first symptom related to other causes that are traumatic, myogenic, neurogenic, or mechanical in nature.
Studying the impact of topical steroids on ptosis
September 08, 2021
Why instillation of topical corticosteroids may be associated with greater ptosis and higher rate of failed ptosis repair
Considering double-organ bias in clinical trials of eyelid ptosis
September 01, 2021
Investigators searched PubMed over the past 2 decades for clinical trials on eyelid ptosis using the terms blepharoptosis or upper eyelid ptosis or eyelid ptosis” and the filters “randomized controlled trial (RCT), clinical trial, and humans.”
Corneal keratometry and corneal astigmatism changes after surgery for acquired ptosis
August 24, 2021
Researchers conducted a retrospective observational study to assess the corneal refractive changes induced by surgery to correct ptosis using Fourier harmonic analysis.
Considering older age, high BMI as risks for blepharoptosis in Korean patients
August 19, 2021
A study suggests that for the general population, evaluation for blepharoptosis should be done at 66 years of age, or at 63 and 70 years for males and females, separately.